News RSS Feed
May 12, 2010
Smith Medical Partners Obtains Agreement to Distribute Leading Oncology Drugs from Endo Pharmaceuticals
Smith Medical Partners is pleased to announce an agreement with Endo Pharmaceuticals to distribute VANTAS® (histrelin implant), VALSTAR® (valrubicin) and SUPPRELIN® LA (histrelin acetate) subcutaneous implant.
December 6, 2009
Smith Medical Partners to Distribute Significant Plasma Products
The following Grifols plasma derivatives are now available through Smith Medical Partners: Alphanate, Alphanine and Profilnine.
